AorTech buys worldwide rights for new materials for heart valves
This article was originally published in Clinica
Executive Summary
The Scottish company, AorTech, will use some of the £3 million ($5 million) it has raised in a share offering to buy exclusive worldwide rights to a range of polyurethanes which it hopes to use in its heart valves.